Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3336984 | Transfusion Medicine Reviews | 2007 | 6 Pages |
Abstract
In Canada, intravenous immune globulin (IVIG) use has increased by 115% over the past 7 to 8 years. Given this increased usage, Canadian Blood Services and the National Advisory Committee on Blood and Blood Products for Canada identified the need to develop and disseminate evidence-based guidelines to facilitate appropriate IVIG use. As a result, guidelines for IVIG use in hematologic and neurologic conditions have been developed and are published in this supplement of Transfusion Medicine Reviews. This commentary provides a brief description of the process used to develop these guidelines and includes a summary of the recommendations for IVIG use in the various conditions evaluated.
Related Topics
Health Sciences
Medicine and Dentistry
Hematology
Authors
Paula Robinson, David Anderson, Melissa Brouwers, Thomas E. Feasby, Heather Hume,